|
Click here to view online. Add this email to your safelist. |
|||||||||||
|
|
|||||||||||
|
AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts |
|||||||||||
|
|
|||||||||||
|
29 April 2022
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world leading life sciences hub. |
|||||||||||
|